TARGETING OF MYC BY HDAC INHIBITION IN MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA

被引：0
|
作者：
Ecker, Jonas [1 ,2 ,3 ,4 ]
Oehme, Ina [1 ,2 ]
Selt, Florian [1 ,2 ,3 ,4 ]
Kool, Marcel [2 ,5 ]
Chavez, Lukas [2 ,5 ]
Hohloch, Juliane [1 ,2 ]
Valinciute, Gintvile [1 ,2 ]
van Tilburg, Cornelis M. [3 ,4 ]
Schnolzer, Martina [6 ]
Warnken, Uwe [6 ]
Wechsler-Reya, Robert [7 ]
Pfister, Stefan M. [2 ,3 ,4 ,5 ]
Witt, Olaf [1 ,2 ,3 ,4 ]
Milde, Till [1 ,2 ,3 ,4 ]
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
[3] German Canc Res Ctr, Ctr Individualized Pediat Oncol ZIPO & Brain Tumo, Translat Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[4] German Canc Co, Heidelberg, Germany
[5] German Canc Res Ctr, Div Pediat Neurooncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany
[6] German Canc Res Ctr, Funct Proteome Anal B100, Heidelberg, Germany
[7] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MEDU-20
引用
收藏
页码：41 / 42
页数：3
相关论文
共 50 条
  • [1] Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
    Ecker, Jonas
    Thatikonda, Venu
    Sigismondo, Gianluca
    Selt, Florian
    Valinciute, Gintvile
    Oehme, Ina
    Mueller, Carina
    Buhl, Juliane L.
    Ridinger, Johannes
    Usta, Diren
    Qin, Nan
    van Tilburg, Cornelis M.
    Herold-Mende, Christel
    Remke, Marc
    Sahm, Felix
    Westermann, Frank
    Kool, Marcel
    Wechsler-Reya, Robert J.
    Chavez, Lukas
    Krijgsveld, Jeroen
    Jaeger, Natalie
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    NEURO-ONCOLOGY, 2021, 23 (02) : 226 - 239
  • [2] TARGETING AUTOPHAGY IN MYC AMPLIFIED MEDULLOBLASTOMA
    Bagchi, Aditi
    MacKeigan, Jeffery
    Cornelius, Albert
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S70 - S70
  • [3] Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1
    Zhao, Yang
    Li, Tiantian
    Tian, Shuaiwei
    Meng, Wei
    Sui, Yi
    Yang, Jian
    Wang, Baocheng
    Liang, Zhuangzhuang
    Zhao, Heng
    Han, Yipeng
    Tang, Yujie
    Zhang, Lei
    Ma, Jie
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12473 - 12485
  • [4] Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
    Ecker, Jonas
    Oehme, Ina
    Mazitschek, Ralph
    Korshunov, Andrey
    Kool, Marcel
    Hielscher, Thomas
    Kiss, Judit
    Selt, Florian
    Konrad, Carina
    Lodrini, Marco
    Deubzer, Hedwig E.
    von Deimling, Andreas
    Kulozik, Andreas E.
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 22
  • [5] Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
    Jonas Ecker
    Ina Oehme
    Ralph Mazitschek
    Andrey Korshunov
    Marcel Kool
    Thomas Hielscher
    Judit Kiss
    Florian Selt
    Carina Konrad
    Marco Lodrini
    Hedwig E Deubzer
    Andreas von Deimling
    Andreas E Kulozik
    Stefan M Pfister
    Olaf Witt
    Till Milde
    Acta Neuropathologica Communications, 3
  • [6] HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
    Shofuda, Tomoko
    Kanemura, Yonehiro
    NEURO-ONCOLOGY, 2021, 23 (02) : 173 - 174
  • [7] BET BROMODOMAIN INHIBITION OF MYC-AMPLIFIED MEDULLOBLASTOMA
    Bandopadhayay, P.
    Nguyen, B.
    Masoud, S.
    Vue, N.
    Gholamin, S.
    Yu, F.
    Schubert, S.
    Bergthold, G.
    Mitra, S.
    Cheshire, S.
    Qi, J.
    Bradner, J. E.
    Kieran, M. W.
    Beroukhim, R.
    Cho, Y. J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 36 - 36
  • [8] SYNERGISTIC DRUG COMBINATIONS FOR THE TREATMENT OF MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA
    Zeuner, Simon
    Vollmer, Johanna
    Peterziel, Heike
    Sigaud, Romain
    Oppermann, Sina
    ElHarouni, Dina
    Hielscher, Thomas
    Witt, Olaf
    Oehme, Ina
    Milde, Till
    Ecker, Jonas
    NEURO-ONCOLOGY, 2021, 23 : 7 - 8
  • [9] BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
    Bandopadhayay, Pratiti
    Bergthold, Guillaume
    Nguyen, Brian
    Schubert, Simone
    Gholamin, Sharareh
    Tang, Yujie
    Bolin, Sara
    Schumacher, Steven E.
    Zeid, Rhamy
    Masoud, Sabran
    Yu, Furong
    Vue, Nujsaubnusi
    Gibson, William J.
    Paolella, Brenton R.
    Mitra, Siddhartha S.
    Cheshier, Samuel H.
    Qi, Jun
    Liu, Kun-Wei
    Wechsler-Reya, Robert
    Weiss, William A.
    Swartling, Fredrik J.
    Kieran, Mark W.
    Bradner, James E.
    Beroukhim, Rameen
    Cho, Yoon-Jae
    CLINICAL CANCER RESEARCH, 2014, 20 (04) : 912 - 925
  • [10] BET BROMODOMAIN INHIBITION OF MYC-AMPLIFIED MEDULLOBLASTOMA
    Bandopadhayay, Pratiti
    Nguyen, Brian
    Masoud, Sabran
    Vue, Nujsaubnusi
    Gholamin, Sharareh
    Yu, Furong
    Schubert, Simone
    Bergthold, Guillaume
    Mitra, Siddhartha
    Qi, Jun
    Bradner, James
    Kieran, Mark
    Beroukhim, Rameen
    Cho, Yoon-Jae
    NEURO-ONCOLOGY, 2013, 15 : 36 - 36
12345